AR071222A1 - Compuestos heterociclicos espirocondensados - Google Patents

Compuestos heterociclicos espirocondensados

Info

Publication number
AR071222A1
AR071222A1 ARP090101487A ARP090101487A AR071222A1 AR 071222 A1 AR071222 A1 AR 071222A1 AR P090101487 A ARP090101487 A AR P090101487A AR P090101487 A ARP090101487 A AR P090101487A AR 071222 A1 AR071222 A1 AR 071222A1
Authority
AR
Argentina
Prior art keywords
alkyl
methyl
spiro
plasmodium
indole
Prior art date
Application number
ARP090101487A
Other languages
English (en)
Spanish (es)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40613087&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR071222(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR071222A1 publication Critical patent/AR071222A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ARP090101487A 2008-04-29 2009-04-27 Compuestos heterociclicos espirocondensados AR071222A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08155342 2008-04-29
EP09151117 2009-01-22

Publications (1)

Publication Number Publication Date
AR071222A1 true AR071222A1 (es) 2010-06-02

Family

ID=40613087

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090101487A AR071222A1 (es) 2008-04-29 2009-04-27 Compuestos heterociclicos espirocondensados

Country Status (31)

Country Link
US (2) US8053442B2 (ko)
EP (2) EP2722333A1 (ko)
JP (2) JP5438098B2 (ko)
KR (1) KR101390081B1 (ko)
CN (1) CN102015711B (ko)
AR (1) AR071222A1 (ko)
AU (1) AU2009242279B2 (ko)
BR (1) BRPI0911577B8 (ko)
CA (1) CA2719365C (ko)
CL (1) CL2009001007A1 (ko)
CO (1) CO6300940A2 (ko)
CY (1) CY1114874T1 (ko)
DK (1) DK2285808T3 (ko)
EA (1) EA019601B1 (ko)
EC (2) ECSP10010646A (ko)
ES (1) ES2447590T3 (ko)
HK (1) HK1149935A1 (ko)
HR (1) HRP20140151T1 (ko)
IL (1) IL208357A (ko)
JO (1) JO2904B1 (ko)
MA (1) MA32316B1 (ko)
MX (1) MX2010011868A (ko)
MY (2) MY156601A (ko)
NZ (1) NZ588217A (ko)
PE (1) PE20091787A1 (ko)
PL (1) PL2285808T3 (ko)
PT (1) PT2285808E (ko)
SI (1) SI2285808T1 (ko)
TW (1) TWI442921B (ko)
WO (1) WO2009132921A1 (ko)
ZA (1) ZA201006752B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2719365C (en) * 2008-04-29 2017-03-07 Novartis Ag Spiro-indole derivatives for the treatment of parasitic diseases
CN102584835B (zh) * 2011-01-17 2014-08-27 苏州大学 一种含吲哚结构的螺杂环化合物及其制备方法
CN104185634B (zh) * 2012-03-23 2017-05-03 诺华股份有限公司 制备螺旋吲哚酮和其中间体的化学工艺
RU2662815C2 (ru) * 2012-03-23 2018-07-31 Новартис Аг Химический способ получения спироиндолонов и их промежуточных соединений
WO2013142770A1 (en) 2012-03-23 2013-09-26 Codexis, Inc. Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
EP3068793B1 (en) 2013-11-13 2021-02-17 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
SG11201703258PA (en) 2014-11-25 2017-05-30 Codexis Inc Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
MY198354A (en) 2014-12-18 2023-08-28 Hoffmann La Roche Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
UA120385C2 (uk) * 2015-01-23 2019-11-25 Глаксосмітклайн Інтеллектьюел Проперті Девелопмент Лімітед ПОХІДНА ПІРАЗОЛО[3,4-d]ПІРИМІДИНУ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ЛІКУВАННІ ЛЕЙШМАНІОЗУ
WO2016147205A1 (en) * 2015-03-13 2016-09-22 Council Of Scientific & Industrial Research Novel substituted 3-spirophosphoryl pyrazole-2-oxindoles as anti-infectives and process for the synthesis thereof
US11174267B2 (en) 2015-06-12 2021-11-16 The Regents Of The University Of California Spiroindolinones and therapeutic uses thereof
JP2017024992A (ja) * 2015-07-15 2017-02-02 公益財団法人微生物化学研究会 化合物の製造方法
HUE064542T2 (hu) 2018-06-21 2024-03-28 Hoffmann La Roche A 3-((1R,3R)1(2,6-difluoro-4-((1-(3-fluoropropil)azetidin-3-il)amino)fenil)-3-metil-1,3,4,9 -tetrahidro-2H-pirido[3,4-b]indol-2-il)-2,2-difluoropropán-1-ol tartarátsó szilárd formái, eljárás elõállításukra és rákos megbetegedések kezelésében történõ alkalmazási módszereik
CN110590795B (zh) * 2019-10-10 2021-01-22 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 一类多并杂环螺羟吲哚类化合物的合成方法
WO2021186348A1 (en) * 2020-03-17 2021-09-23 The University Of Buea Dihydro-spiro[indoline-3:1'-isoquinolin]-2-ones as antimalarial agents
CN116273188B (zh) * 2023-03-01 2024-06-25 岭南师范学院 一种负载金属的多孔有机框架材料在催化Pictet-Spengler反应中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663935A1 (fr) * 1990-06-27 1992-01-03 Adir Nouveaux 1,2,3,4,5,6-hexahydroazepino [4,5-b] indoles et 1,2,3,4-tetrahydrobethacarbolines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
CA2337119A1 (en) * 1998-07-14 2000-01-27 Richard K. Haynes Antiparasitic artemisinin derivatives (endoperoxides)
JP4601175B2 (ja) 1998-12-19 2010-12-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗ヒスタミン性スピロ化合物
US20050143371A1 (en) * 2003-07-23 2005-06-30 Pharmacia Corporation Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
AR053710A1 (es) 2005-04-11 2007-05-16 Xenon Pharmaceuticals Inc Compuestos espiroheterociclicos y sus usos como agentes terapeuticos
ATE469900T1 (de) 2006-12-07 2010-06-15 Hoffmann La Roche Spiropiperidinderivate als antagonisten des via- rezeptors
JP2011507910A (ja) * 2007-12-21 2011-03-10 ユニバーシティー オブ ロチェスター 真核生物の寿命を変更するための方法
WO2009089454A1 (en) 2008-01-09 2009-07-16 Array Biopharma Inc. Pyrimidyl cyclopentanes as akt protein kinase inhibitors
CA2719365C (en) * 2008-04-29 2017-03-07 Novartis Ag Spiro-indole derivatives for the treatment of parasitic diseases

Also Published As

Publication number Publication date
CA2719365A1 (en) 2009-11-05
PT2285808E (pt) 2014-02-24
ES2447590T3 (es) 2014-03-12
US20110275613A1 (en) 2011-11-10
CN102015711B (zh) 2013-05-01
IL208357A0 (en) 2010-12-30
AU2009242279B2 (en) 2012-08-30
PE20091787A1 (es) 2009-12-14
BRPI0911577B1 (pt) 2021-02-23
JP2014065729A (ja) 2014-04-17
CA2719365C (en) 2017-03-07
MY152021A (en) 2014-08-15
JP5438098B2 (ja) 2014-03-12
EP2285808B1 (en) 2013-11-20
EA019601B1 (ru) 2014-04-30
MX2010011868A (es) 2010-11-26
US8053442B2 (en) 2011-11-08
ECSP17068127A (es) 2017-10-31
AU2009242279A1 (en) 2009-11-05
BRPI0911577B8 (pt) 2021-05-25
BRPI0911577A8 (pt) 2018-03-06
SI2285808T1 (sl) 2014-03-31
MY156601A (en) 2016-03-15
WO2009132921A1 (en) 2009-11-05
JP2011518852A (ja) 2011-06-30
CO6300940A2 (es) 2011-07-21
ECSP10010646A (es) 2010-12-30
US20090275560A1 (en) 2009-11-05
EA201001689A1 (ru) 2011-08-30
EP2285808A1 (en) 2011-02-23
CN102015711A (zh) 2011-04-13
PL2285808T3 (pl) 2014-04-30
TW200948357A (en) 2009-12-01
HK1149935A1 (en) 2011-10-21
HRP20140151T1 (hr) 2014-03-28
JO2904B1 (en) 2015-09-15
IL208357A (en) 2014-11-30
MA32316B1 (fr) 2011-05-02
CY1114874T1 (el) 2016-12-14
KR20100135320A (ko) 2010-12-24
KR101390081B1 (ko) 2014-04-29
CL2009001007A1 (es) 2010-06-11
EP2722333A1 (en) 2014-04-23
NZ588217A (en) 2012-10-26
DK2285808T3 (da) 2014-02-03
ZA201006752B (en) 2011-05-25
US8399453B2 (en) 2013-03-19
BRPI0911577A2 (pt) 2016-01-05
TWI442921B (zh) 2014-07-01

Similar Documents

Publication Publication Date Title
AR071222A1 (es) Compuestos heterociclicos espirocondensados
AR064561A1 (es) Derivados de 2-aza-biciclo[3.1.0]hexano y su uso en la preparacion de un medicamento para el tratamiento de enfermedades relacionadas con disfunciones generales del sistema de la orexina.
MA46452B1 (fr) Composés de benzo[b]thiophéne en tant qu'agonistes de sting
AR070459A1 (es) Derivados de 2-aza-biciclo- [2,2,1] heptano
AR085615A1 (es) Derivados de fluoropiridinona utiles como agentes antibacterianos y composiciones farmaceuticas que los contienen
AR075090A1 (es) Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
PE20150399A1 (es) Nuevos derivados de pirrol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR048241A1 (es) Compuestos azufrados como inhibidores de la serina proteasa ns3 del virus de la hepatitis c .
AR067757A1 (es) Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales.
AR050953A1 (es) Compuestos de sulfonamida inhibidores de los receptores de cck1/cck2 duales
AR057894A1 (es) Derivados de tiofeno
AR062360A1 (es) Derivados heterociclicos que modulan la actividad de la estearoil-coa-desaturasa
AR078163A1 (es) Utilizacion de aminodihidrotiazinas para el tratamiento o prevencion de la diabetes
AR072906A1 (es) Nucleosidos modificados utiles como antivirales
AR078609A1 (es) 8-etil-6-(aril)pirido[2,3-d]pirimidin-7(8h)-onas, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de trastornos del sistema nervioso central,tales como depresion y canceres de ovario y renales, entre otros.
BRPI0517314A (pt) derivados de indol e benzimidazol
AR039203A1 (es) Derivados de quinazolina
PE20121526A1 (es) Compuestos policiclicos heterociclicos como inhibidores del virus de la hepatitis c
PE20141205A1 (es) Spiro-[1,3]-oxacinas y spiro-[1,4]-oxacepinas como inhibidores de bace1 y/o bace2
AR031556A1 (es) Derivados de 3-(diarilmetilen)-8-azabiciclo[3.2.1] octano y composiciones farmaceuticas que los comprenden
AR047076A1 (es) Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas
AR060914A1 (es) Derivados de furopiridina como ligandos receptores de la acetilcolina nicotinica, una composicion farmaceutica que los comprende y su empleo en la manufactura de un medicamento para el tratamiento de una enfermedad mediada por la activacion del receptor alfa7-nicotinico.
DOP2012000053A (es) Derivados de (tio) morfolina como moduladores de s1p
AR080703A1 (es) Derivados de 3-(heteroaril-amino)-1,2,3,4-tetrahidro-9h-carbazol, moduladores de receptores de prostaglandina d2, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos alergicos o inmunitarios tales como asma.
PE20211456A1 (es) Compuestos de sulfonimidoilpurinona 7-sustituidos y sus derivados para el tratamiento y prevencion del cancer de higado

Legal Events

Date Code Title Description
FG Grant, registration